No abstract available
Keywords:
Checkpoint inhibitors; Immune-related adverse events; Inflammatory myopathy; Myasthenia gravis; Myocarditis.
MeSH terms
-
Antibodies, Monoclonal, Humanized* / adverse effects
-
Humans
-
Myositis*
Substances
-
Antibodies, Monoclonal, Humanized
-
pembrolizumab